Patient-Centric

Challenges biotech companies are facing as patients expectations are increasing Ensuring the end-to-end supply chain can respond in the face of fierce competition for innovation Leveraging data and analytics to increase value and service to patients Keeping patients central as external factors accelerate need for resiliency — Kimberly Lounds Foster SVP Global Supply Chain Bristol-Myers Squibb Kimberly Lounds Foster is Senior Vice President, Global Supply Chain at Bristol-Myers Squibb, where she oversees the clinical and commercial supply chain. Bristol develops and manufactures products on multiple technology platforms, including small molecules, biologics and cell therapies. Kimberly joined Bristol through the Celgene…